Audrey Rasmussen - Concepedia

Author

Audrey Rasmussen

Georgetown University

Also Known As

A A Rasmussen, A Rasmussen, A. Rasmussen, A.A. Rasmussen, Adam Davis Rasmussen, Audrey A. Rasmussen, Audrey Rasmussen

Publications

936

Citations

H-Index

Concepts

All Affiliations

Georgetown University Georgetown University Medical Center Cancer Research Center University of Pisa Kanazawa University

About

Audrey Rasmussen is an author at Georgetown University specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	646
2	Cell Biology	7	7	366
3	Pathology	7	7	536
4	Pharmacology	3	3	233
5	Immunology	2	2	151

Audrey Rasmussen

Publications

726

Citations

H-Index

Page 1

	Year	Citations
Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Christian F. Singer, Audrey Rasmussen, Helene S. Smith, PubMed Paracrine InteractionsBreast OncologyPathologyParacrine FunctionMammary Gland Development	1995	134
Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Hideaki Shiga, Elisabeth I. Heath, Audrey Rasmussen, PubMed Neck CancerChemoprevention StrategyNeoadjuvant TherapyPathologyTumor Biology	1999	120
Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer. T Nishimura, Kenneth Newkirk, R B Sessions, PubMed Neck CancerImmunologyPathologyMetronomic ChemotherapyImmunotherapy	1996	85
The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer K.-L.G. Spindler, Niels Pallisgaard, Audrey Rasmussen, Annals of Oncology Kras MutationsG PolymorphismGastrointestinal OncologyMedicinePathology	2009	75
Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Matthew J. Ellis, Brett Leav, Zhi-Zheng Yang, Molecular Endocrinology Breast OncologyImmunologyCancer BiologyTumor BiologySignaling Pathway	1996	66
IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: Anin situ hybridization and immunohistochemistry study Claudio Giani, Kevin J. Cullen, Daniela Campani, Breast Cancer Research and Treatment Tumor BiologyBreast OncologyOncologyAnin Situ HybridizationMedicine	1996	62
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines Zejia Yang, Patrick J. Faustino, Paul A. Andrews, Cancer Chemotherapy and Pharmacology Cisplatin ResistanceCancer ResearchChromatinOncologyOncogenic Agent	2000	46
Distribution and mRNA Expression of Insulin-Like Growth Factor System in Pulmonary Lymphangioleiomyomatosis Julio C. Valencia, Kazuhiro Matsui, Carolyn A. Bondy, Journal of Investigative Medicine	2001	35
Prognostic value ofc-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer Hideaki Shiga, Audrey Rasmussen, Patrick G. Johnston, Head & Neck	2000	32
Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines Kenneth Newkirk, Joseph Heffern, Erik Sloman-Moll, Cancer Chemotherapy and Pharmacology Cisplatin ResistanceOncologyMedicinePharmacologyGlutathione Content	1997	28

Page 1